| COVID-19 |
1 |
1 |
| Acute Respiratory Distress Syndrome |
0 |
0.79 |
| Biomarker |
0 |
0.62 |
| Cerebrovascular Accident |
0 |
0.55 |
| Severe Acute Respiratory Syndrome |
0 |
0.43 |
| Brain |
0 |
0.39 |
| Wound Management |
0 |
0.38 |
| Thromboembolism |
0 |
0.32 |
| Injury |
0 |
0.31 |
| Plasma |
0 |
0.31 |
| Alzheimer Disease |
0 |
0.99 |
| Neuroinflammation |
0 |
0.23 |
| New York |
0 |
0.23 |
| Cognition |
0 |
0.95 |
| Dementia |
0 |
0.15 |
| Neurologic Complication |
0 |
0.9 |
| Amyloid-Beta |
0 |
0.08 |
| Dorsum |
0 |
0.08 |
| Encephalopathy |
0 |
0.08 |
| Geriatrics |
0 |
0.08 |
| Ischemia |
0 |
0.08 |
| Ischemic Stroke |
0 |
0.08 |
| Match |
0 |
0.08 |
| Metabolism |
0 |
0.08 |
| Middle Eastern Respiratory Syndrome (MERS) |
0 |
0.08 |
| Seizure |
0 |
0.08 |
| Viral Infection |
0 |
0.08 |